Peptides with anticancer use or potential
- 30 January 2003
- journal article
- review article
- Published by Springer Nature in Amino Acids
- Vol. 25 (1) , 1-40
- https://doi.org/10.1007/s00726-002-0349-x
Abstract
This review is an attempt to illustrate the diversity of peptides reported for a potential or an established use in cancer therapy. With 612 references, this work aims at covering the patents and publications up to year 2000 with many inroads in years 2001–2002. The peptides are classed according to four categories of effective (or plausible) biological mechanisms of action: receptor—interacting compounds; inhibitors of protein-protein interaction; enzymes inhibitors; nucleic acid—interacting compounds. The fifth group is made of the peptides for which no mechanism of action has been found yet. Incidentally this work provides an overview of many of the modern targets of anticancer research.Keywords
This publication has 426 references indexed in Scilit:
- Peptides Encoded by Exon 6 of VEGF Inhibit Endothelial Cell Biological Responses and Angiogenesis Induced by VEGFBiochemical and Biophysical Research Communications, 2001
- Novel Lymphocyte Growth-Inhibiting Tripeptide: N-Acetyl-Glu-Ser-GlyNH2Biochemical and Biophysical Research Communications, 2000
- In VitroInhibition of Ras–Raf Association by Short PeptidesBiochemical and Biophysical Research Communications, 1998
- A Hypothetical Structural Role for Proline Residues in the Flanking Segments of Protein-Protein Interaction SitesBiochemical and Biophysical Research Communications, 1995
- A Small Peptide Derived from the Aminoterminus of c-Raf-1 Inhibits c-Raf-1/Ras BindingBiochemical and Biophysical Research Communications, 1995
- SH2 and SH3 domainsCurrent Biology, 1993
- Ser Asp Lys-Ac, A strong inhibitor of liver cell proliferationThe Science of Nature, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogueBiochemical and Biophysical Research Communications, 1988
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982